U.S. Markets open in 8 hrs 13 mins
  • S&P Futures

    3,432.75
    -19.00 (-0.55%)
     
  • Dow Futures

    28,030.00
    -159.00 (-0.56%)
     
  • Nasdaq Futures

    11,619.25
    -44.25 (-0.38%)
     
  • Russell 2000 Futures

    1,621.30
    -14.30 (-0.87%)
     
  • Crude Oil

    39.11
    -0.74 (-1.86%)
     
  • Gold

    1,899.30
    -5.90 (-0.31%)
     
  • Silver

    24.39
    -0.28 (-1.16%)
     
  • EUR/USD

    1.1839
    -0.0030 (-0.2486%)
     
  • 10-Yr Bond

    0.8410
    0.0000 (0.00%)
     
  • Vix

    27.55
    -0.56 (-1.99%)
     
  • GBP/USD

    1.3029
    -0.0009 (-0.0717%)
     
  • USD/JPY

    104.8950
    +0.2050 (+0.1958%)
     
  • BTC-USD

    13,134.46
    +39.01 (+0.30%)
     
  • CMC Crypto 200

    264.02
    +2.56 (+0.98%)
     
  • FTSE 100

    5,860.28
    +74.63 (+1.29%)
     
  • Nikkei 225

    23,491.34
    -25.25 (-0.11%)
     

A Trio of Stock Picks for Growth-Focused Investors

GuruFocus.com
·3 mins read

- By Alberto Abaterusso

Growth-focused investors may be interested in the following stocks since their price-earnings ratios still trade below 20 and their trailing 12-month earnings per share have grown significantly over the past year.

Corcept Therapeutics Inc

The first company that makes the cut is Corcept Therapeutics Inc (NASDAQ:CORT), a Menlo Park, California-based biotechnology developer of treatments for U.S. patients affected by serious metabolic, oncologic and psychiatric disorders.


Year over year, the company's trailing 12-month net earnings have grown by 47% to 94 cents per share as of the second quarter of 2020, up from 64 cents per share in the same quarter of 2019.

The price-earnings ratio is 18.32 (versus the industry median of 48.64) as of Sept. 17.

Following a 25.3% increase over the past year, the stock was trading at $17.22 per share at close on Thursday for a market capitalization of $1.99 billion and a 52-week range of $9.70 to $23.48.

A Trio of Stock Picks for Growth-Focused Investors
A Trio of Stock Picks for Growth-Focused Investors

Corcept Therapeutics Inc does not pay dividends.

GuruFocus assigned a score of 8 out of 10 to the company's financial strength and a score of 5 out of 10 to its profitability.

Wall Street sell-side analysts recommend an overweight rating for this stock and have set an average target price of $17.75 per share.

Lumber Liquidators Holdings Inc

The second company that qualifies is Lumber Liquidators Holdings Inc (NYSE:LL), Richmond, Virginia-based multi-channel home improvement specialty retailer selling hard-surface flooring and flooring enhancements, including accessories.

The company's trailing 12-month net earnings were $1.12 per share as of the second quarter of 2020, marking a positive switch from a net loss of $2.05 as of the same quarter of 2019.

The price-earnings ratio is 19.29 (versus the industry median of 21.73) as of Sept. 17.

As a result of a 143.6% increase over the past year, the stock traded at $21.61 per share at close on Thursday for a market capitalization of $623.51 million and a 52-week range of $3.77 to $29.60.

A Trio of Stock Picks for Growth-Focused Investors
A Trio of Stock Picks for Growth-Focused Investors

Lumber Liquidators Holdings Inc does not pay dividends.

GuruFocus rated the financial strength of the company with a score of 4 out of 10 and the profitability with a score of 6 out of 10.

Wall Street sell-side analysts issued a hold rating for this stock and have established an average target price of $22 per share.

Pro-Dex Inc

The third company that makes the cut is Pro-Dex Inc (NASDAQ:PDEX), an Irvine, California-based developer of medical instruments and supplies for global original equipment manufacturers.

The company's trailing 12-month net earnings have advanced 56.7% on a year over year basis to $1.52 per share as of the second quarter of 2020, up from 97 cents in the second quarter of 2019.

The price-earnings ratio is 19.22 (versus the industry median of 35.66) as of Sept. 17.

After a 92.33% share price uptick over the past year, the stock was trading at $29.60 per share at close on Thursday for a market capitalization of $113.61 million and a 52-week range of $11.40 to $32.98.

A Trio of Stock Picks for Growth-Focused Investors
A Trio of Stock Picks for Growth-Focused Investors

Pro-Dex Inc does not pay dividends.

GuruFocus assigned a score of 8 out of 10 for the company's financial strength and a score of 7 out of 10 for its profitability.

The stock has a buy recommendation rating with an average target price of $30 per share on Wall Street.

Disclosure: I have no positions in any securities mentioned in this article.

Read more here:



Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.

This article first appeared on GuruFocus.